213 related articles for article (PubMed ID: 34864789)
1. Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease : A Systematic Review and Meta-analysis.
Tariq R; Syed T; Yadav D; Prokop LJ; Singh S; Loftus EV; Pardi DS; Khanna S
J Clin Gastroenterol; 2023 Mar; 57(3):285-293. PubMed ID: 34864789
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of fecal microbiota transplant for recurrent Clostridium difficile infection in inflammatory bowel disease: a systematic review and meta-analysis.
Cheng F; Huang Z; Li Z; Wei W
Rev Esp Enferm Dig; 2022 Sep; 114(9):543-549. PubMed ID: 35510325
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
[TBL] [Abstract][Full Text] [Related]
4. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
Hirten RP; Grinspan A; Fu SC; Luo Y; Suarez-Farinas M; Rowland J; Contijoch EJ; Mogno I; Yang N; Luong T; Labrias PR; Peter I; Cho JH; Sands BE; Colombel JF; Faith JJ; Clemente JC
Inflamm Bowel Dis; 2019 May; 25(6):969-979. PubMed ID: 30852592
[TBL] [Abstract][Full Text] [Related]
5. Effect of Faecal Microbiota Transplantation for Treatment of Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Cohort Studies.
Chen T; Zhou Q; Zhang D; Jiang F; Wu J; Zhou JY; Zheng X; Chen YG
J Crohns Colitis; 2018 May; 12(6):710-717. PubMed ID: 29528385
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
Tariq R; Disbrow MB; Dibaise JK; Orenstein R; Saha S; Solanky D; Loftus EV; Pardi DS; Khanna S
Inflamm Bowel Dis; 2020 Aug; 26(9):1415-1420. PubMed ID: 31821444
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysis.
Porcari S; Baunwall SMD; Occhionero AS; Ingrosso MR; Ford AC; Hvas CL; Gasbarrini A; Cammarota G; Ianiro G
J Autoimmun; 2023 Dec; 141():103036. PubMed ID: 37098448
[TBL] [Abstract][Full Text] [Related]
8. The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis.
Qazi T; Amaratunga T; Barnes EL; Fischer M; Kassam Z; Allegretti JR
Gut Microbes; 2017 Nov; 8(6):574-588. PubMed ID: 28723262
[TBL] [Abstract][Full Text] [Related]
9. Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort.
Suchman K; Luo Y; Grinspan A
Dig Dis Sci; 2022 Oct; 67(10):4866-4873. PubMed ID: 35000023
[TBL] [Abstract][Full Text] [Related]
10. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
[TBL] [Abstract][Full Text] [Related]
11. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
[TBL] [Abstract][Full Text] [Related]
12. Fecal Microbiota Transplantation and Medical Therapy for Clostridium difficile Infection : Meta-analysis of Randomized Controlled Trials.
Singh T; Bedi P; Bumrah K; Gandhi D; Arora T; Verma N; Schleicher M; Rai MP; Garg R; Verma B; Sanaka MR
J Clin Gastroenterol; 2022 Nov-Dec 01; 56(10):881-888. PubMed ID: 34516460
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
[TBL] [Abstract][Full Text] [Related]
14. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center.
Ianiro G; Bibbò S; Porcari S; Settanni CR; Giambò F; Curta AR; Quaranta G; Scaldaferri F; Masucci L; Sanguinetti M; Gasbarrini A; Cammarota G
Gut Microbes; 2021; 13(1):1994834. PubMed ID: 34709989
[TBL] [Abstract][Full Text] [Related]
15. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis.
Porcari S; Severino A; Rondinella D; Bibbò S; Quaranta G; Masucci L; Maida M; Scaldaferri F; Sanguinetti M; Gasbarrini A; Cammarota G; Ianiro G
J Autoimmun; 2023 Dec; 141():103033. PubMed ID: 37085337
[TBL] [Abstract][Full Text] [Related]
16. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S
Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622
[TBL] [Abstract][Full Text] [Related]
17. Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
Fischer M; Kao D; Kelly C; Kuchipudi A; Jafri SM; Blumenkehl M; Rex D; Mellow M; Kaur N; Sokol H; Cook G; Hamilton MJ; Phelps E; Sipe B; Xu H; Allegretti JR
Inflamm Bowel Dis; 2016 Oct; 22(10):2402-9. PubMed ID: 27580384
[TBL] [Abstract][Full Text] [Related]
18. FMT: What's Next? A Narrative Review of Fecal Microbiota Transplantation in Clostridioides difficile Infection and Inflammatory Bowel Disease.
Patwa SA; Ward C; Kelly CR
R I Med J (2013); 2022 Nov; 105(9):20-24. PubMed ID: 36300959
[TBL] [Abstract][Full Text] [Related]
19. Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
Tariq R; Pardi DS; Bartlett MG; Khanna S
Clin Infect Dis; 2019 Apr; 68(8):1351-1358. PubMed ID: 30957161
[TBL] [Abstract][Full Text] [Related]
20. Predictors of failure after fecal microbiota transplantation for recurrent Clostridioides difficile infection: a systematic review and meta-analysis.
Tariq R; Hayat M; Pardi D; Khanna S
Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1383-1392. PubMed ID: 33496893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
